Skip to main content
Displaying 1 - 12 of 32
Display:
12
24
48
Liver Tumours
New trends in HCC Epidemiology and Therapeutic approach
Webcasts
View
Liver Tumours
Diagnostic Advances in Focal Liver Lesions: role of MRI and liver specific agents
Webcasts
View
Liver Tumours
Interventional therapy for HCC: how to optimize patient selection and improve clinical outcomes
Webcasts
View
Liver Tumours
Conclusion and Q&A
Webcasts
View
Liver Tumours
Introduction
Webcasts
View
Liver Tumours
Bayer: Evolving horizons in HCC diagnosis and therapy (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Introduction
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Case Based Discussion on Biochemical Normalization
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Case Based Discussion on QOL/Pruritus
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Conclusion
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Understanding New Goals of Therapy in PBC
Webcasts
View
Pagination
Current page
1
Page
2
Page
3
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy